Publicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (1)

2024

  1. Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)

    British Journal of Cancer, Vol. 130, Núm. 3, pp. 434-441